other:Article Title: Neogenin-loss in neural crest cells results in persistent hyperplastic primary vitreous formation
Article Snippet: The primary antibodies used in the experiments were anti-PH3 (1:500, Millipore), anti-Ki67 (1:400, Millipore), anti-MiTF (1:400, Abcam), anti-AP2 β (1:300, Cell Signaling Technology), anti-CD31 (1:500, BD), anti-PDGFR β (1:500, Abcam), anti-Sox9 (1:300, Millipore), anti-FoxD3 (1:300, Cell Signaling Technology), and anti-Sox10 (1:300, Cell Signaling Technology).
Article Title: FOXD3 promotes homologous recombination repair and genomic stability by facilitating MRE11-mediated DNA end resection.
Article Snippet: Antibodies The following antibodies were used in this study: anti-FLAG M2 (Sigma-Aldrich), anti-FOXD3 (2019S; Cell Signaling Technology, Danvers, USA), anti-FOXD3 (27878-1-AP; Proteintech, Wuhan, China), anti-GST (66001-2-Ig; Proteintech), anti-ACTIN (AC026; ABclonal, Wuhan, China), anti-PARP1 (13371-1-AP; Proteintech), anti-BRCA1 (22362-1-AP; Proteintech), anti-RPA32 (10412-1-AP; Proteintech), anti-RPA32 (A300-244A; Bethyl, Montgomery, USA), anti-pRPA32 S33 (A300-246A; Bethyl), anti-ATM (A300-299A; Bethyl), anti-pATM S1981 (ab82192; Abcam, Cambridge, UK), anti-gamma H2AX (A300-081A; Bethyl), anti-gamma H2AX (80312S; Cell Signaling Technology), anti-IdU (347580; BD Biosciences, Franklin Lakes, USA), anti-Histone H3 (ab176842; Abcam), anti-RAD51 (ab133534; Abcam), anti-MRE11 (Genetex, GTX70212), anti-RAD50 (A300-185A; Bethyl), anti-NBS1 (14956S; Cell Signaling Technology), and anti-pCHK2 T68 (2661S; Cell Signaling Technology).
Article Title: FOXD3 promotes homologous recombination repair and genomic stability by facilitating MRE11-mediated DNA end resection
Article Snippet: The following antibodies were used in this study: anti-FLAG M2 (Sigma-Aldrich), anti-FOXD3 (2019S; Cell Signaling Technology, Danvers, USA), anti-FOXD3 (27878-1-AP; Proteintech, Wuhan, China), anti-GST (66001-2-Ig; Proteintech), anti-ACTIN (AC026; ABclonal, Wuhan, China), anti-PARP1 (13371-1-AP; Proteintech), anti-BRCA1 (22362-1-AP; Proteintech), anti-RPA32 (10412-1-AP; Proteintech), anti-RPA32 (A300-244A; Bethyl, Montgomery, USA), anti-pRPA32 S33 (A300-246A; Bethyl), anti-ATM (A300-299A; Bethyl), anti-pATM S1981 (ab82192; Abcam, Cambridge, UK), anti-gamma H2AX (A300-081A; Bethyl), anti-gamma H2AX (80312S; Cell Signaling Technology), anti-IdU (347580; BD Biosciences, Franklin Lakes, USA), anti-Histone H3 (ab176842; Abcam), anti-RAD51 (ab133534; Abcam), anti-MRE11 (Genetex, GTX70212), anti-RAD50 (A300-185A; Bethyl), anti-NBS1 (14956S; Cell Signaling Technology), and anti-pCHK2 T68 (2661S; Cell Signaling Technology).
|